Enovis Corporation Price to Sales Ratio 2010-2024 | ENOV
Historical PS ratio values for Enovis Corporation (ENOV) over the last 10 years. The current P/S ratio for Enovis Corporation as of February 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Enovis Corporation P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-02-21 |
42.71 |
|
1.17 |
| 2024-09-30 |
43.05 |
$36.44 |
1.18 |
| 2024-06-30 |
45.20 |
$35.02 |
1.29 |
| 2024-03-31 |
62.45 |
$33.31 |
1.88 |
| 2023-12-31 |
56.02 |
$31.34 |
1.79 |
| 2023-09-30 |
52.73 |
$30.55 |
1.73 |
| 2023-06-30 |
64.12 |
$29.99 |
2.14 |
| 2023-03-31 |
53.49 |
$29.37 |
1.82 |
| 2022-12-31 |
53.52 |
$28.87 |
1.85 |
| 2022-09-30 |
46.07 |
$18.00 |
2.56 |
| 2022-06-30 |
55.00 |
$17.70 |
3.11 |
| 2022-03-31 |
68.49 |
$17.39 |
3.94 |
| 2021-12-31 |
79.12 |
$29.03 |
2.73 |
| 2021-09-30 |
79.00 |
$7.72 |
10.23 |
| 2021-06-30 |
78.85 |
$18.45 |
4.27 |
| 2021-03-31 |
75.40 |
$25.12 |
3.00 |
| 2020-12-31 |
65.82 |
$23.82 |
2.76 |
| 2020-09-30 |
53.98 |
$67.94 |
0.79 |
| 2020-06-30 |
48.02 |
$68.96 |
0.70 |
| 2020-03-31 |
34.08 |
$75.26 |
0.45 |
| 2019-12-31 |
62.62 |
$73.29 |
0.85 |
| 2019-09-30 |
50.02 |
$59.43 |
0.84 |
| 2019-06-30 |
48.24 |
$54.17 |
0.89 |
| 2019-03-31 |
51.08 |
$47.95 |
1.07 |
| 2018-12-31 |
35.97 |
$53.90 |
0.67 |
| 2018-09-30 |
62.07 |
$36.43 |
1.70 |
| 2018-06-30 |
52.75 |
$43.58 |
1.21 |
| 2018-03-31 |
54.91 |
$50.42 |
1.09 |
| 2017-12-31 |
68.19 |
$46.90 |
1.45 |
| 2017-09-30 |
71.67 |
$72.98 |
0.98 |
| 2017-06-30 |
67.76 |
$71.24 |
0.95 |
| 2017-03-31 |
67.57 |
$74.06 |
0.91 |
| 2016-12-31 |
61.84 |
$77.62 |
0.80 |
| 2016-09-30 |
54.10 |
$76.08 |
0.71 |
| 2016-06-30 |
45.54 |
$80.65 |
0.56 |
| 2016-03-31 |
49.21 |
$81.87 |
0.60 |
| 2015-12-31 |
40.19 |
$82.37 |
0.49 |
| 2015-09-30 |
51.48 |
$99.17 |
0.52 |
| 2015-06-30 |
79.43 |
$103.78 |
0.77 |
| 2015-03-31 |
82.15 |
$107.90 |
0.76 |
| 2014-12-31 |
88.76 |
$113.77 |
0.78 |
| 2014-09-30 |
98.06 |
$119.28 |
0.82 |
| 2014-06-30 |
128.30 |
$117.80 |
1.09 |
| 2014-03-31 |
122.77 |
$118.02 |
1.04 |
| 2013-12-31 |
109.62 |
$120.16 |
0.91 |
| 2013-09-30 |
97.23 |
$118.99 |
0.82 |
| 2013-06-30 |
89.69 |
$122.82 |
0.73 |
| 2013-03-31 |
80.10 |
$127.04 |
0.63 |
| 2012-12-31 |
69.45 |
$129.63 |
0.54 |
| 2012-09-30 |
63.12 |
$107.84 |
0.59 |
| 2012-06-30 |
47.45 |
$89.13 |
0.53 |
| 2012-03-31 |
60.65 |
$68.67 |
0.88 |
| 2011-12-31 |
49.02 |
$46.99 |
1.04 |
| 2011-09-30 |
34.87 |
$46.40 |
0.75 |
| 2011-06-30 |
42.69 |
$44.00 |
0.97 |
| 2011-03-31 |
39.50 |
$39.81 |
0.99 |
| 2010-12-31 |
31.69 |
$37.35 |
0.85 |
| 2010-09-30 |
25.59 |
$34.97 |
0.73 |
| 2010-06-30 |
17.92 |
$34.76 |
0.52 |
| 2010-03-31 |
20.26 |
$35.26 |
0.57 |
| 2009-12-31 |
20.72 |
$36.38 |
0.57 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
